Ask AI

Managing Influenza in the High-Risk Patient

Following a PCE Symposia Live Stream Series an expert in infectious diseases and influenza gives his personal perspectives on influenza treatment and post-exposure chemoprophylaxis strategies in immunosuppressed adults and children including optimal use of neuraminidase inhibitors (NAIs) and baloxavir.

Share

Program Content

No activities added yet

Supporters

This activity is supported by an educational grant from

Genentech, a member of the Roche Group